Jost Fischer Biography and Net Worth

Director of AEON Biopharma

Jost Fischer has served on the board of directors of AEON since February 2017 and serves on the board of directors as a representative of Dental Innovations BVBA. Mr. Fischer is the co-owner of Dental Innovations BVBA. Mr. Fischer served as a member and the chairman of the board of directors and as Chief Executive Officer of Sirona from June 2006 to February 2013, as Chief Executive Officer from April 2002 to February 2013, and as President from April 2002 to September 2010. Prior to joining Sirona, Mr. Fischer served as President and Chief Executive Officer of The Hoermann Group, an international conglomerate in the telecommunication and automotive industry, and held senior management positions with PWA Group, a European paper group, including President and Chief Executive Officer of PWA’s printing division and President and Chief Executive Officer of PWA Dekor GmbH. In addition, Mr. Fischer serves on the board of directors of a number of private companies. Mr. Fischer received a Masters Degree in Economics from the University of Saarbruecken, Germany.

What is Jost Fischer's net worth?: The estimated net worth of Jost Fischer is at least $59.97 thousand as of May 20th, 2025. Fischer owns 206,785 shares of AEON Biopharma stock worth more than $59,968 as of October 6th. This net worth estimate does not reflect any other investments that Fischer may own. Learn More about Jost Fischer's net worth.
How do I contact Jost Fischer?: The corporate mailing address for Fischer and other AEON Biopharma executives is 130 Vantis Drive, Suite 170, Aliso Viejo, CA, 92656. AEON Biopharma can also be reached via phone at (949) 354-6499. Learn More on Jost Fischer's contact information.
Has Jost Fischer been buying or selling shares of AEON Biopharma?: Jost Fischer has not been actively trading shares of AEON Biopharma within the last three months. Most recently, on Tuesday, May 20th, Jost Fischer bought 60,000 shares of AEON Biopharma stock. The stock was acquired at an average cost of $0.51 per share, with a total value of $30,600.00. Following the completion of the transaction, the director now directly owns 206,785 shares of the company's stock, valued at $105,460.35. Learn More on Jost Fischer's trading history.
Are insiders buying or selling shares of AEON Biopharma?: During the last year, AEON Biopharma insiders bought shares 1 times. They purchased a total of 1,150,000 shares worth more than $241,500.00. The most recent insider tranaction occured on August, 19th when Major Shareholder Timothy P Lynch bought 1,150,000 shares worth more than $241,500.00. Insiders at AEON Biopharma own 9.4% of the company. Learn More about insider trades at AEON Biopharma.
Information on this page was last updated on 8/19/2026.

Jost Fischer Insider Trading History at AEON Biopharma

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
5/20/2025	Buy	60,000	$0.51	$30,600.00	206,785
5/19/2025	Buy	50,000	$0.50	$25,000.00	146,785

Jost Fischer Buying and Selling Activity at AEON Biopharma

AEON Biopharma Company Overview

AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of both chronic and episodic migraine, as well as develops ABP-450 for the treatment of gastroparesis and posttraumatic stress disorder. The company is based in Irvine, California.

Today's Range

Now: $0.29

$0.26

$0.29

50 Day Range

MA: $0.26

$0.19

$0.33

2 Week Range

Now: $0.29

$0.18

$1.45

Volume

1,076,779 shs

Average Volume

2,927,621 shs

Market Capitalization

$14.37 million

P/E Ratio

1.60

Dividend Yield

N/A

Beta

0.69